Symbol="EYPT"
AssetType="Common Stock"
Name="Eyepoint Pharmaceuticals Inc"
Description="EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and markets ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company is headquartered in Watertown, Massachusetts."
CIK="1314102"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="LABORATORY ANALYTICAL INSTRUMENTS"
Address="480 PLEASANT STREET, SUITE B300, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="429803000"
EBITDA="-84496000"
PERatio="None"
PEGRatio="None"
BookValue="1.524"
DividendPerShare="0"
DividendYield="0"
EPS="-2.58"
RevenuePerShareTTM="0.997"
ProfitMargin="-2.838"
OperatingMarginTTM="-2.297"
ReturnOnAssetsTTM="-0.262"
ReturnOnEquityTTM="-1.016"
RevenueTTM="37333000"
GrossProfitTTM="26948000"
DilutedEPSTTM="-2.58"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.213"
AnalystTargetPrice="31.75"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.154"
PriceToBookRatio="0.727"
EVToRevenue="0.112"
EVToEBITDA="0.162"
Beta="1.297"
num_52WeekHigh="13.23"
num_52WeekLow="2.19"
num_50DayMovingAverage="8.48"
num_200DayMovingAverage="5.31"
SharesOutstanding="34301900"
DividendDate="2020-12-09"
ExDividendDate="None"
symbol="EYPT"
open="12.58"
high="13.23"
low="12.51"
price="12.90"
volume="405014.00"
latest_trading_day="2023-08-04"
previous_close="12.53"
change="0.37"
change_percent="2.9529%"
aroon_positive_momentum_days="78"
aroon_negative_momentum_days="0"
trend_strength="Strong Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="78"
Volume_recent_avg="785988"
Change_recent_avg="0.08"
Delta_recent_avg="0.68"
Variance_recent_avg="0.34"
Change_ratio_recent_avg="0.92"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="78"
Aroon_momentum_negative="22"
image_negative_thumbnail_id_1="1139"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0172.jpeg"
image_negative_thumbnail_id_2="145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0031.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="673"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0035.jpeg"
image_positive_thumbnail_id_2="613"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0095.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
